http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103028119-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2011-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103028119-B |
| titleOfInvention | Application of miR-132 in preparation of drug for treating parkinsonism |
| abstract | The invention relates to application of miR-132 in preparation of a drug for treating parkinsonism. The miR-132 has a nucleotide sequence shown as SEQ ID NO.16. The invention further provides application of using miR-132 as a diagnosis molecular marker in preparing a product for diagnosing parkinsonism. The application has the advantages as follows: the action of the miR-132 in DA (Dopamine) neurons growth is firstly verified; a target gene of the miR-132 is verified as an important transcription factor Nurr1 in the DA neurons growth and PD (Parkinsonism); and the miRNA is of great significance to the parkinsonism, and clinical diagnosis and treatment. |
| priorityDate | 2011-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 187.